Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
Part of paid clinical trials in Newport Beach, California.
- Sponsor
- Aadi Bioscience, Inc.
- Study ID
- NCT05997056
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Gastrointestinal Neuroendocrine Tumor
- NET
- Neuroendocrine Tumors
- Pancreatic Neuroendocrine Tumor
- Pulmonary Neuroendocrine Tumor
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- nab-sirolimus — DRUGProspective phase 2 single arm, open-label, multi-institutional study to determine the efficacy and safety prospective of nab-sirolimus administered by IV infusion
Study Details
A Phase 2 multi-center, open-label, single arm study of nab-sirolimus in patients with well-differentiated neuroendocrine tumors (NETs) of the gastrointestinal tract, lung, or pancreas who have not received prior treatment with mTOR inhibitors
Key Dates
- Start date
- Nov 7, 2023
- Status verified
- Jul 2024
- Primary completion
- May 9, 2025
- Completion
- Dec 8, 2025
Study Design
- Enrollment
- 21 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: neuroendocrine tumorsPatients with well-differentiated neuroendocrine tumors of the gastrointestinal tract, lung, or pancreas.
Primary Outcome Measure
Efficacy of nab-sirolimus [ Time Frame: 12 Months ]
Central Contacts
- Aadi Bioscience Medical Information1-888-246-2234
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92663 | Jason Ledesma Michael Demeure, MD (PRINCIPAL_INVESTIGATOR) |
| Rocky Mountain Cancer Centers | Denver | Colorado | 80218 | Jennifer Hedge Allen Cohn, MD (PRINCIPAL_INVESTIGATOR) |
| Texas Oncology | Dallas | Texas | 75246 | Christine Terraciano Scott Paulson, MD (PRINCIPAL_INVESTIGATOR) |
| Medical College of Wisconsin Cancer Center | Milwaukee | Wisconsin | 53226 | Alexandria T Phan, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Newport Beach, CA
By condition
By specialty
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Dose-defining Study of Tirapazamine Combined With Embolization in Liver CancerPHASE1/PHASE2 · Recruiting · Teclison Ltd. · Palo Alto, California
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine TumorsRecruiting · Methodist Health System · Dallas, Texas